Background: Atrial septal aneurysm (ASA) has been considered a potential source of cardiogenic embolism for many years. The ASA Multicenter Italian (ASA-MI) Study evaluated the prevalence and characteristics of ASA in patients with stroke and normal carotid arteries compared with control patients without stroke. The purpose of the present study was to evaluate the frequency of ASA and the association with patent foramen ovale (PFO) in the subgroup of younger patients (aged less than 55 years) included in the ASA-MI Study. Methods: The ASA-MI Study included 606 patients, enrolled between November 1990 and December 1996: 245 patients with a previous cerebral embolic attack and normal carotid study and a control group of 316 patients. They all underwent transthoracic and transesophageal echocardiography. The subgroup of younger patients aged less than 55 years included 90 patients (61 men and 29 women of mean age 49 ± 5 years) (group AY). This group was evaluated and compared with an age- and sex-matched control population (61 men; of mean age 48 ± 6 years) (group BY). Results: The prevalence of ASA was 48.8% (95% confidence interval 40–61) in group AY and 22.2% in the group BY (95% confidence interval 18–33) (χ2 = 5.968; p = 0.01). Morphological features were similar in the 2 groups of patients. ASA involved the entire septum in 52% of patients of group AY, and in 47.2% of group BY. The prevalence of PFO was 58.8% (95% confidence interval 43–62) in group AY and 28.8% in group BY (95% confidence interval 17–35) (χ2 = 5.811; p = 0.01). A strong association was found between ASA and PFO. Of the 90 younger patients with stroke, 39 of 44 (88.6%) with ASA also had PFO, compared with 14 of 46 (30.4%) without ASA (χ2 = 7.370; p = 0.007). Conclusion: We found that ASA and PFO were independent predictive factors for stroke in younger patients with stroke and normal carotid arteries and that the association between ASA and PFO bore an increased odds risk.

Keywords:
Stroke, Transesophageal echocardiography, Patent foramen ovale, Atrial septal aneurysm
1.
Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, et al: Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785–2792.
2.
Silver MD, Dorsey JS: Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978;102:62–65.
3.
Mattioli AV, Aquilina M, Oldani A, Longhini C, Mattioli G: Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid artery. A multicentre study. Eur Heart J 2001;22:261–268.
4.
Agmon Y, Khandheria BK, Meissner I, Gentile F, Whisnant JP, Sicks JRD, O’Fallon M, Covalt JL, Wiebers DO, Seward JB: Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999;99:1942–1944.
5.
Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke. Neurology 2000;55:1172–1179.
6.
Cerebral Embolism Task Force: Cardiogenic brain embolism: The second report of Cerebral Embolism Task Force. Arch Neurol 1989;46:727–743.
7.
Seward JB, Khandheria BK, Oh JK, Abel MD, Hughes RW Jr, Edwards WD, Nichols BA, Freeman WK, Tajik AJ: Transesophageal echocardiography: Technique, anatomic correlation, implementations and clinical applications. Mayo Clin Proc 1988;63:649–680.
8.
Mattioli AV, Aquilina M, Bonetti L, Oldani A, Longhini C, Mattioli G: Transesophageal echocardiography in patients with recent stroke and normal carotid arteries. Am J Cardiol 2001;88:820–823.
9.
Gilon D, Buonanno FS, Joffe MM, Favitt MI, Marshall JE, Kistler JP, Levine RA: Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med 1999;341:8–13.
10.
Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ: Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1–7.
11.
Pearson A, Nagelhout D, Castello R, Gomez CR, Labovitz AJ: Atrial septal aneurysm and stroke: A transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223–1229.
12.
Strandness DE: Duplex Scanning in Vascular Disorders. New York, Raven Press, 1990, pp 92–120.
13.
Meissner I, Whisnant JP, Khanderia BK, Spittel PC, O’Fallon WM, Pascoe RD, Enriquez-Sarano M, Seward JB, Covalt JL, Sicks JD, Wiebers DO: Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC study. Mayo Clin Proc 1999;74:862–869.
14.
Roijer A, Lindgren A, Rudling O, Wallin L, Olsson SB, Johansson BB, Eskilsson J: Potential cardioembolic sources in an elderly population without stroke. A transthoracic and transesophageal echocardiographic study in randomly selected volunteers. Eur Heart J 1996;17:1103–1111.
15.
Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guerin F, Bousser MG, de Recondo J: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. Stroke 1993;24:1865–1873.
16.
Nighoghossian N, Perinetti M, Barthelet M, Adeleine P, Trouillas P: Potential cardioembolic sources of stroke in patients less than 60 years of age. Eur Heart J 1996;17:590–594.
17.
Belkin RN, Hurwitz BJ, Kisslo J: Atrial septal aneurysm: Association with cerebrovascular and peripheral embolic events. Stroke 1987;18:856–862.
18.
Schneider B, Harath P, Vogel P, Meinertz T: Improved morphologic characterization of atrial septal aneurysm by trasesophageal echocardiography: Relation to cerebrovascular events. J Am Coll Cardiol 1990;16:1000–1009.
19.
Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL: Patent foramen ovale: Is stroke due to paradoxical embolism? Stroke 1993;24:31–34.
20.
Rice MJ, McDonald RW, Reller MD: Fetal atrial septal aneurysm: A cause of fetal atrial arrhythmias. J Am Coll Cardiol 1988;12:1292–1297.
21.
Berthet K, Lavergne T, Cohen A, Giuze L, Bousser MG, Le Heuzey JY, Amarenco P: Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398–403.
22.
Ravelli F, Allessie M: Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997;96:1686–1695.
23.
Mas JL: Patent foramen ovale, stroke and paradoxical embolism. Cerebrovasc Dis 1991;1:181–183.
24.
Landi G, D’Angelo A, Boccardi E, Candelise L, Mannucci PM, Morabito A, Orazio EN: Venous thromboembolism in acute stroke: Prognostic importance of hypercoagulability. Arch Neurol 1992;49:279–283.
25.
Kerut EK, Norfleet WT, Plotnick GD, Giles TD: Patent foramen ovale: A review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613–623.
26.
Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740–1746.
27.
Schuchlenz HW, Weihs W, Horner S, Quehenberger F: The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456–462.
28.
Stone DA, Godard J, Corretti MC, et al: Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1998;131:158–161.
29.
Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, Meier B: Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893–898.
30.
Labovitz AJ: Transesophageal echocardiography and unexplained cerebral ischemia: A multicenter follow-up study. The STEPS Investigators. Am Heart J 1999;137:1082–1087.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.